Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 741 |
|---|---|
| 2: Name of authorisation holder | MAWDSLEY-BROOKS & COMPANY LIMITED |
| 3: Address(es) of manufacturing site(s) |
MAWDSLEY-BROOKS & COMPANY LIMITED, UNIT 22, QUEST PARK, WHEATLEY HALL ROAD, DONCASTER, DN2 4LT, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | MAWDSLEY-BROOKS & COMPANY LIMITED, UNIT 3, SOUTH LANGWORTHY ROAD, PO BOX 18, SALFORD, M50 2PW, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 02/12/2022 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
MAWDSLEY-BROOKS & COMPANY LIMITED, UNIT 22, QUEST PARK, WHEATLEY HALL ROAD, DONCASTER, DN2 4LT, UNITED KINGDOM
Human Investigational Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.5 ] Packaging |
| [ 1.5.2 ] Secondary packaging |
| Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
| [ 2.2 ] Batch certification of imported medicinal products |
| [ 2.2.1 ] Sterile Products |
| [ 2.2.1.1 ] Aseptically prepared |
| [ 2.2.1.2 ] Terminally sterilised |
| [ 2.2.2 ] Non-sterile products |
| [ 2.2.3 ] Biological medicinal products |
| [ 2.2.3.1 ] Blood products |
| [ 2.2.3.2 ] Immunological products |
| [ 2.2.3.3 ] Cell therapy products |
| [ 2.2.3.4 ] Gene therapy products |
| [ 2.2.3.5 ] Biotechnology products |
| [ 2.2.3.6 ] Human or animal extracted products |
| [ 2.3 ] Other Importation Activities |
| [ 2.3.1 ] Site of Physical Importation |
| [ 2.3.4 ] Other Importation of QP-certified IMPs from a country on the approved country for import list |